The Library
Browse by Warwick Author
Up a level |
Jump to: Journal Article | Journal Item
Number of items: 11.
Journal Article
Underwood, Martin, Achana, Felix, Carnes, Dawn, Eldridge, Sandra, Ellard, David R., Griffiths, Frances, Haywood, Kirstie, Hee, Siew Wan, Higgins, Helen, Mistry, Dipesh et al.
(2023)
A supportive self-management program for people with chronic headaches and migraine : a randomized controlled trial and economic evaluation.
Neurology, 100 (13)
(13).
e1339-e1352.
doi:10.1212/WNL.0000000000201518
ISSN 0028-3878.
OPTIMA Trial Management Group (Including: Bartlett, John M. S., Bayani, Jane, Kornaga, Elizabeth N., Danaher, Patrick, Crozier, Cheryl, Piper, Tammy, Yao, Cindy Q., Dunn, Janet A., Boutros, Paul C. and Stein, Robert C.). (2020) Computational approaches to support comparative analysis of multiparametric tests : modelling versus training. PLOS ONE, 15 (9). e0238593. doi:10.1371/journal.pone.0238593 ISSN 1932-6203.
Earl, Helena, Hiller, Louise, Vallier, Anne-Laure, Loi, Shrushma, McAdam, Karen, Hughes-Davies, Luke, Rea, Daniel, Howe, Donna L., Raynes, Kerry, Higgins, Helen B. et al.
(2020)
Six versus 12 monthsβ adjuvant trastuzumab in patients with HER2-positive early breast cancer : the PERSEPHONE non-inferiority RCT.
Health Technology Assessment, 24
(40).
pp. 1-190.
doi:10.3310/hta24400
ISSN 1366-5278.
Drayson, Mark T, Bowcock, Stella, Planche, Tim, Iqbal, Gulnaz, Pratt, Guy, Yong, Kwee, Wood, Jill, Raynes, Kerry, Higgins, Helen B., Dawkins, Bryony et al.
(2019)
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM) : a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
The Lancet. Oncology, 20
(12).
pp. 1760-1772.
doi:10.1016/S1470-2045(19)30506-6
ISSN 1470-2045.
Earl, Helena M., Hiller, Louise, Vallier, Anne-Laure, Loi, Shrushma, McAdam, Karen, Hughes-Davies, Luke, Harnett, Adrian N, Ah-See, Mei-Lin, Simcock, Richard, Rea, Daniel et al.
(2019)
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE) : 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
The Lancet, 393
(10191).
pp. 2599-2612.
doi:10.1016/S0140-6736(19)30650-6
ISSN 0140-6736.
Bartlett, J., Canney, P., Campbell, A. M., Cameron, D., Donovan, Jenny, Dunn, Janet A., Earl, Helena M., Francis, A., Hall, P., Harmer, V. et al.
(2013)
Selecting breast cancer patients for chemotherapy : the opening of the UK OPTIMA trial.
Clinical Oncology, Volume 25
(Number 2).
pp. 109-116.
doi:10.1016/j.clon.2012.10.005
ISSN 0936-6555.
Hiller, Louise, Dunn, Janet A., Higgins, Helen B., Ogburn-Storey, Emma, Loi, Shrushma, Vallier, Anne-Laure and Earl, Helena M. (2011) Optimising patient recall of adverse events over prolonged time periods. Trials, Vol.12 (Suppl.1). A74. doi:10.1186/1745-6215-12-S1-A74 ISSN 1745-6215.
Journal Item
Atkin, C., Drayson, M., Iqbal, Gulnaz, Yong, K., Pratt, G., Planche, T., Wood, J., Raynes, K., Higgins, Helen B., Dunn, Janet A. and Bowcock, S. (2018) Presenting symptoms of patients with multiple myeloma : data from the TEAMM (Tackling EArly Morbidity and Mortality in Myeloma) trial. British Journal of Haematology, 181 (Supplement 1). pp. 5-211. BSH18-PO-094 [pp 96]. ISSN 0007-1048 doi:10.1111/bjh.15226
Stein, R. C., Makris, A., Hughes-Davies, L., Macpherson, I. R., Hall, P. S., Cameron, D. A., Earl, H. M., Pinder, S. E., Poole, C. J., Rea, D. W. et al.
(2018)
OPTIMA : A prospective randomized trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in early breast cancer.
Cancer Research, 78
(4).
Abstract OT1-06-01.
ISSN 0008-5472
doi:10.1158/1538-7445.SABCS17-OT1-06-01
Poole, Christopher J., Marshall, A. (Andrea)β, Higgins, Helen B., Fletcher, J., Williams, S. J., Lo, N., Fernando, I. N., Osborne, R., Crawford, S. M., Rafii, S., Gill, S. and Dunn, Janet A. (2012) Neo-escape : Neoadjuvant extended sequential chemotherapy with adjuvant postoperative treatment for epithelial nonmucinous advanced inoperable peritoneal malignancy. Journal of Clinical Oncology, 30 (15). p. 1. ISSN 0732-183X
Marshall, A. (Andrea), Dunn, Janet A., Fletcher, Julie, Higgins, Helen B. and Poole, Christopher (2011) The importance of planning for a seamless transition in an adaptive phase II randomised trial. Trials, Vol.12 (Suppl.1). A7. ISSN 1745-6215 doi:10.1186/1745-6215-12-S1-A7
This list was generated on Thu Apr 18 08:15:55 2024 BST.